Literature DB >> 20299293

An improved high-performance liquid chromatography-tandem mass spectrometric method to measure atrazine and its metabolites in human urine.

Parinya Panuwet1, Paula A Restrepo, Melina Magsumbol, Kyung Y Jung, M Angela Montesano, Larry L Needham, Dana Boyd Barr.   

Abstract

We report an improved solid-phase extraction-high-performance liquid chromatography-tandem mass spectrometry method with isotope dilution quantification to measure seven atrazine metabolites in urine. The metabolites measured were hydroxyatrazine (HA), diaminochloroatrazine (DACT), desisopropylatrazine (DIA), desethylatrazine (DEA), desethylatrazine mercapturate (DEAM), atrazine mercapturate (ATZM), and atrazine (ATZ). Using offline mixed-mode reversed-phase/cation-exchange solid-phase extraction dramatically increased recovery and sensitivity by reducing the influence of matrix components during separation and analysis. DACT extraction recovery improved to greater than 80% while the other analytes had similar extraction efficiencies as previously observed. Limits of detection were lower than our previous method (0.05-0.19 ng/mL) with relative standard deviations less than 10%. The total runtime was shorter (18 min) than the previous on-line method, thus it is suitable for large-scale sample analyses. We increased the throughput of our method twofold by using the newer extraction technique. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299293     DOI: 10.1016/j.jchromb.2010.02.025

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Two-dimensional high performance liquid chromatography separation and tandem mass spectrometry detection of atrazine and its metabolic and hydrolysis products in urine.

Authors:  Zsuzsanna Kuklenyik; Parinya Panuwet; Nayana K Jayatilaka; James L Pirkle; Antonia M Calafat
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-06-02       Impact factor: 3.205

2.  In utero exposure to atrazine analytes and early menarche in the Avon Longitudinal Study of Parents and Children Cohort.

Authors:  Gonza Namulanda; Ethel Taylor; Mildred Maisonet; Dana Boyd Barr; W Dana Flanders; David Olson; Judith R Qualters; John Vena; Kate Northstone; Luke Naeher
Journal:  Environ Res       Date:  2017-04-12       Impact factor: 6.498

3.  Urinary biomarkers of prenatal atrazine exposure and adverse birth outcomes in the PELAGIE birth cohort.

Authors:  Cécile Chevrier; Gwendolina Limon; Christine Monfort; Florence Rouget; Ronan Garlantézec; Claire Petit; Gaël Durand; Sylvaine Cordier
Journal:  Environ Health Perspect       Date:  2011-03-02       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.